1. Home
  2. HTLD vs JANX Comparison

HTLD vs JANX Comparison

Compare HTLD & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heartland Express Inc.

HTLD

Heartland Express Inc.

HOLD

Current Price

$10.88

Market Cap

738.1M

Sector

Industrials

ML Signal

HOLD

Logo Janux Therapeutics Inc.

JANX

Janux Therapeutics Inc.

HOLD

Current Price

$14.97

Market Cap

790.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTLD
JANX
Founded
1978
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
738.1M
790.3M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
HTLD
JANX
Price
$10.88
$14.97
Analyst Decision
Hold
Strong Buy
Analyst Count
5
11
Target Price
$10.00
$53.60
AVG Volume (30 Days)
296.8K
961.6K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
0.73%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$805,709,000.00
$10,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$8.63
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.00
$12.12
52 Week High
$12.13
$35.34

Technical Indicators

Market Signals
Indicator
HTLD
JANX
Relative Strength Index (RSI) 59.74 61.23
Support Level $10.66 $13.10
Resistance Level $11.54 $15.49
Average True Range (ATR) 0.30 0.57
MACD 0.12 0.11
Stochastic Oscillator 69.47 81.33

Price Performance

Historical Comparison
HTLD
JANX

About HTLD Heartland Express Inc.

Heartland Express Inc, along with its subsidiaries, operates as a short, medium, and long-haul truckload carrier and transportation services provider. It mainly provides nationwide asset-based dry van truckload service for shippers across the United States, along with cross-border freight and other transportation services offered through third-party partnerships in Mexico. The group operates under the brand names of Heartland Express, Millis Transfer, Smith Transport, and CFI (for services within Mexico).

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Share on Social Networks: